๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Sepsis-induced cholestasis

โœ Scribed by Nisha Chand; Arun J. Sanyal


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
404 KB
Volume
45
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Sepsis-induced cholestasis
โœ Kurt Lenz; Christine Kapral; Fritz Firlinger; Fritz Wewalka ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 45 KB

Hepatic dysfunction and jaundice is a common finding in patients with septic shock. In their excellent review, Dr. Nisha Chand and Prof. Arun J. Sanyal draw attention to an early and suitable management of the underlying infection as the only effective management known yet to improve hepatic dysfunc

Sepsis-induced cholestasis
โœ Ivo Giovannini; Carlo Chiarla; Felice Giuliante; Maria Vellone; Francesco Ardito ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 43 KB
Cholestasis of sepsis
โœ Richard K Gilroy; Mark E Mailliard; John L Gollan ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 104 KB

Cholestasis of sepsis is a form of hepatocellular cholestasis that occurs as a result of sepsis. Usually, prior to the development of cholestasis, the manifestations of sepsis dominate the clinical picture. The occurrence of cholestasis is without direct bacterial involvement of the biliary system a

Drug-induced cholestasis
โœ Manmeet S. Padda; Mayra Sanchez; Abbasi J. Akhtar; James L. Boyer ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 442 KB

Recent progress in understanding the molecular mechanisms of bile formation and cholestasis have led to new insights into the pathogenesis of drug-induced cholestasis. This review summarizes their variable clinical presentations, examines the role of transport proteins in hepatic drug clearance and

Clinicopathology conferences: Inflammati
โœ James M. Crawford; James L. Boyer ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 372 KB

Intrahepatic cholestasis may arise from many sources, and it therefore presents a particular challenge when it develops in the seriously ill patient. A 54-year-old patient with a myeloproliferative disorder is presented, who developed jaundice in the setting of a severe decubital infection, polyphar